Refocusing metrics: can the sustainable development goals help break the ‘metrics trap’ and modernise international drug control policy?
Refocusing metrics: can the sustainable development goals help break the ‘metrics trap’ and modernise international drug control policy?
复制标题
重新关注指标：可持续发展目标能否帮助打破“指标陷阱”并使国际药物管制政策现代化？
DOI：
10.1108/dat-12-2016-0033
复制
发表时间：
2017
影响因子：
0.9
通讯作者：
D. Bewley
中科院分区：
文献类型：
--
作者：
D. Bewley
目的
Purpose
The purpose of this paper is to examine the extent to which the dominant metrics currently used to measure the success of the UN based global drug prohibition regime are in many ways inadequate and consequently contribute to systemic inertia. Within this context, it seeks to explore the potential of explicitly linking drug policy to the recently launched sustainable development agenda (SDA) and the associated sustainable development goals (SDGs) to initiate a change in approach.
Design/methodology/approach
Framing the topic in terms of international relations (IR) and regime analysis, prominent examples of where current metrics are imprecise (the relationship between production and seizures), misconceived (drug use) and missing (a range of drug and drug policy related harms) are explored. Attention is then given to an examination of international development as a model for measuring drug control outcomes, including a discussion of the SDGs in general and the intersection between drug policy interventions and several goals in particular.
Findings
While aware of the complexity of the issue area, the paper finds that there are considerable shortcomings in the way international drug policy outcomes are currently assessed. Although methodological problems are likely to persist, linking drug policy with the SDGs and their associated metrics offers the potential to help to shift the focus of international policy in a manner that would benefit not only UN system-wide coherence on the issue, but also assist in the achievement of the regime’s own overarching goal; to safeguard the “health and welfare” of humankind.
Practical implications
With the next high-level review of international drug policy due to take place in 2019, the paper offers policy makers with a way to begin to refocus drug policy metrics, and subsequently review outcomes, in line with the UN system-wide SDA.
Originality/value
As an emerging domain of inquiry, the paper not only explores a hitherto largely unexplored – yet increasingly important – facet of UN level policy evaluation, formulation and implementation, but also helps to fill a gap in the IR literature on regime dynamics.